thyroid cancer glp 1 Does drug affect risk? Thyroid and glp1 | TikTok
Description
Many of the aforementioned studies did not report any glucagon outcomes, but some trials found a decrease in postprandial [126] or fasting [129] plasma glucagon concentrations, while others reported no changes in postprandial glucagon secretion following dual incretin receptor agonist treatment [125]
The interactions between GLP-1RAs and other drugs may affect drug efficacy or increase the risk of adverse reactions, as well as the dose adjustment of the combination of hypoglycemic drugs, which put forward higher requirements for clinicians
2 and Additional file 1: Fig
This classification means the product is intended for in vitro laboratory research and is not manufactured, tested, or quality-controlled to pharmaceutical standards
To view or add a comment, sign in 15,169 followers
